The relationship between type 2 diabetes, osteoporosis and aging; The use of transiliac bone biopsy to identify the pathophysiology of skeletal diseases; The effects of osteoporosis treatment on bone stem cells
Kendall Moseley, M.D., is a faculty member of the Division of Endocrinology, Diabetes and Metabolism at both The Johns Hopkins Hospital as well as Johns Hopkins Bayview Medical Center.
Board-certified in Internal Medicine as well as Endocrinology and Metabolism, Dr. Moseley practices general endocrinology with a focus on metabolic bone diseases, osteoporosis, hyperparathyroidism, vitamin D deficiency and calcium abnormalities. She is actively engaged in research involving the relationship between type 2 diabetes, osteoporosis and aging as well as the role of bone stem cells in the regulation of bone remodeling. Clinically, she enjoys working with her patients to individually-tailor effective diet, lifestyle and treatment regimens to improve skeletal health.